MRNA - Will the new type of vaccine revolutionize the fight against cancer?
During the coronavirus pandemic, mRNA technology has impressively demonstrated how fast modern science can work.
The Artikel has sparked my interest again, perhaps an investment in this area will make sense in the coming years and not just be a gamble...
The pharmaceutical and biotech industry now seems to be focusing heavily on mRNA vaccines against cancer. For those who have never really understood how this type of vaccination works; the cure version at the end in the picture :)
Companies like BioNTech, CureVac and Moderna are currently leading the development:
$BNTX (+0,93 %) , known for the first mRNA corona vaccine, is working intensively on the development of over 20 clinical programs against cancer. Some candidates are already in fortgeschrittenen Phasen and could be on the market by 2026
$MRNA (-1,12 %) is currently in the lead with an mRNA vaccine against malignant melanoma. Approval could come even earlier than for BioNTech, more details also hier.
$CVAC (-4,84 %) plans to bring its own mRNA cancer vaccines to market by 2028. A new partnership with the MD Anderson Cancer Center shows the potential for future innovations.
The market for mRNA therapeutics is estimated to be worth over USD 40 billion by 2033. However, the high development costs and other risks must be taken into account; more on this towards the end of the article. Artikel
This article is part of an advertising partnership with Société Générale
